Edition:
United Kingdom

PeptiDream Inc (4587.T)

4587.T on Tokyo Stock Exchange

3,560JPY
5:29am GMT
Change (% chg)

¥-120 (-3.26%)
Prev Close
¥3,680
Open
¥3,715
Day's High
¥3,715
Day's Low
¥3,525
Volume
1,226,700
Avg. Vol
1,003,954
52-wk High
¥3,915
52-wk Low
¥2,450

Latest Key Developments (Source: Significant Developments)

Peptidream announces discovery collaboration agreement with Bayer
Monday, 20 Nov 2017 

Nov 19 (Reuters) - Peptidream Inc <4587.T>:Peptidream announces discovery collaboration agreement with bayer.‍Entered into a multi-target discovery collaboration with Germany-based Bayer AG​.Under terms , co would receive undisclosed upfront payment and research funding.Under terms, co is eligible to receive preclinical, clinical, commercialization milestone payments totaling up to $1.11 billion​.Also eligible to receive royalties on sales of any products that arise from collaboration​.  Full Article

PeptiDream announces discovery collaboration agreement with Bayer AG
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - PeptiDream Inc <4587.T>:Says it announced today that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG.Under the terms of the agreement, it would receive an undisclosed upfront payment and research funding and is eligible to receive preclinical, clinical, and commercialization milestone payments potentially totaling up to $1.11 billion (124.5 billion yen) .In addition, it is eligible to receive royalties on sales of any products that arise from the collaboration .  Full Article

Peptidream announces license of PDPS technology to Genentech Inc
Wednesday, 20 Jul 2016 

PeptiDream Inc <4587.T>: Says it entered into a technology license agreement with U.S.-based company Genentech Inc to nonexclusively license PeptiDream’s proprietary Peptide Discovery Platform System (PDPS) technology . Says PeptiDream will receive an undisclosed upfront payment, annual technology access payments, and is eligible to receive payments based on achievement of certain redetermined development milestones .Says PeptiDream is eligible to receive royalties on sales of certain products that arise from use of the PDPS technology.  Full Article

PeptiDream achieves milestone for initiation of clinical development for bristol-myers squibb’s first collaboration product candidate
Wednesday, 15 Jun 2016 

PeptiDream Inc <4587.T>: Says it has earned a milestone for the dosing of a first patient in a clinical trial by its alliance partner, Bristol-Myers Squibb Company (BMS) . Says this is the first program to enter clinical testing out of the discovery collaboration between the two companies .Says the molecule being advanced in clinical testing was discovered by Bristol-Myers Squibb starting from an active lead macrocyclic compound identified by Peptidream using its PDPS technology and provided to BMS for further optimization.  Full Article

PeptiDream signs joint research and development agreement with SAHI KASEI PHARMA
Monday, 28 Mar 2016 

PeptiDream Inc:Says signed joint research and development agreement with SAHI KASEI PHARMA CORPORATION on March 28 for creating of special cyclic peptide with respect to several drug target protein.  Full Article

PeptiDream announces non-exclusive distribution agreement with Eli Lilly and Company
Thursday, 3 Mar 2016 

PeptiDream Inc:Says reached an agreement with a U.S-based company Eli Lilly and Company, to grant Eli Lilly and Company the non-exclusive distribution rights on PDPS (Peptide Discovery Platform System).  Full Article

PeptiDream signs collaborative research agreement with JCR Pharmaceuticals
Monday, 22 Feb 2016 

PeptiDream Inc:Says signed collaborative research agreement with JCR Pharmaceuticals for development of special cyclic peptide for target protein.  Full Article

PeptiDream signs joint R&D agreement with Shionogi
Friday, 5 Feb 2016 

PeptiDream Inc:Signs joint research and development agreement with Shionogi & Co Ltd on Feb. 5.To start business from Feb. 8.  Full Article

PeptiDream lists on TSE first section
Wednesday, 16 Dec 2015 

PeptiDream Inc:Says began listing on Tokyo Stock Exchange (TSE) first section from TSE Mothers on Dec. 16.  Full Article

PeptiDream announces upgrade of stock listing
Wednesday, 9 Dec 2015 

PeptiDream Inc:To be listed on the Tokyo Stock Exchange (TSE) first section from TSE Mothers.Says the effective date is Dec. 16.  Full Article